View Archive

Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Janssen Scientific Affairs, LLC and Kite Pharma, Inc.

Oncology Town Hall®: Primary Investigators Present Key Abstracts on CAR T-Cell Therapy

Oncology Town Hall®: Primary Investigators Present Key Abstracts on CAR T-Cell Therapy

Thursday, February 18, 2021

Live, Interactive Webcast!

6:00 PM – 7:30 PM EST


The development of chimeric antigen receptor (CAR) T cells continues to change treatment paradigms for patients with hematologic malignancies, with CAR T cells having been approved for patients with acute lymphoblastic leukemia or certain subtypes of non-Hodgkin lymphoma (NHL). More recently, CAR T-cell therapy has demonstrated potential for patients with relapsed/refractory indolent NHL and multiple myeloma. Therefore, health care professionals will be increasingly incorporating CAR T cells during the course of treating their patients with hematologic malignancies.

This activity will update oncology health care professionals with the most recent data from key abstracts presented at major cancer conferences so that they can assess and apply these findings to their clinical practice and ultimately improve care for patients with hematologic malignancies.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Janssen Scientific Affairs, LLC and Kite Pharma, Inc.

Target Audience

This educational activity is directed toward medical oncologists, hematologists, and other oncology health care professionals who treat patients with hematologic malignancies. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of hematologic malignancies are invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Summarize the mechanism of action and unique characteristics of CAR T cells as living therapeutics
  • Discuss key efficacy and safety findings from pivotal trials evaluating CAR T-cell therapies in hematological malignancies
  • Outline proactive strategies to timely recognize and manage treatment-related toxicities in patients who receive CAR T-cell therapies
  • Evaluate the clinical implications of emerging data sets that recently assessed CAR T-cell therapies in the context of evolving treatment paradigms for hematological cancers

Benefits of Attending

  • Hear primary investigators present their findings from recent oncology conferences
  • Understand the clinical impact of recent data with CAR T cells in hematologic malignancies
  • Submit your questions to the expert faculty panel

Hot Topics

  • Updates with CAR T cells in aggressive NHL
  • Newly approved CAR T cells in mantle cell leukemia
  • Emerging CAR T cells in indolent NHL
  • Development of CAR T cells in myeloma

Program Chair

Frederick L. Locke, MD
Frederick L. Locke, MD
Co-Leader, Moffitt Immuno-Oncology Program
Vice Chair and Associate Member
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Tampa, FL


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701

Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By